Immunothrombosis and new-onset atrial fibrillation in the general population: the Rotterdam Study.
Martijn J TillySven GeurtsSamantha J DonkelM Arfan IkramNatasja M S de GrootMoniek P M de MaatMaryam KavousiPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2021)
We found no associations between markers of immunothrombosis and new-onset AF in the general population. Inflammation and immunothrombosis may be associated with AF through other cardiovascular risk factors or predisposing conditions of AF. Our findings challenge the added value of biomarkers in AF risk prediction.